InMed Pharmaceuticals Inc INM:NASDAQ

RT Quote | NASDAQ | USD
Last | 05/19/22 EDT
0.79quote price arrow up+0.01 (+1.28%)
Volume
14,514
52 week range
0.65 - 3.51
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.79
  • 52 Week High3.51
  • 52 Week High Date06/17/21
  • 52 Week Low0.65
  • 52 Week Low Date03/14/22

Key Stats

  • Market Cap7.41M
  • Shares Out9.38M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change-39.69

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.79
  • 52 Week High3.51
  • 52 Week High Date06/17/21
  • 52 Week Low0.65
  • 52 Week Low Date03/14/22
  • Market Cap7.41M
  • Shares Out9.38M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.53
  • YTD % Change-39.69

RATIOS/PROFITABILITY

  • EPS (TTM)-1.21
  • P/E (TTM)-0.65
  • Fwd P/E (NTM)-0.64
  • EBITDA (TTM)-8.038M
  • ROE (TTM)-99.83%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)2.83%

EVENTS

  • Earnings Date09/24/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On InMed Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
InMed Pharmaceuticals Inc. is a clinical stage pharmaceutical company that is engaged in the development, manufacturing and commercialization of rare cannabinoids. The Company is developing a pipeline of prescription-based products targeting treatments for diseases with unmet medical needs as well as developing manufacturing technologies. It is specializing in the research and development of cannabinoid-based therapies and a system for the manufacturing of...
William Garner M.D.
Independent Chairman of the Board
Eric Adams
President, Chief Executive Officer, Director
Brenda Edwards
Interim Chief Financial Officer
Jerry Griffin
Vice President - Sales and Marketing
Address
SUITE 310, 815 W. HASTINGS STREET
Vancouver, BC
V6C 1B4
Canada

Top Peers

SYMBOLLASTCHG%CHG
SBM
PMN
ProMIS Neurosciences Inc
0.10UNCHUNCH
MDNA
Medicenna Therapeutics Corp
1.02-0.04-3.77%
DMAC
DiaMedica Therapeutics Inc
2.42+0.12+5.22%
ONC
AEZS
Aeterna Zentaris Inc
0.203+0.0072+3.68%